Centurion Patentors as of October 29, 2024

James T Dalton

James Tilmon Dalton is an American pharmacist and drug discovery scientist who is also the Executive Vice President and provost of the University of Alabama.

Dalton started as a pharmacist at Kettering Medical Center before becoming an assistant professor at the University of Tennessee, where he led pioneering research on SARMs for muscle loss and developed the cancer/COVID-19 drug sabizabulin.

He rose to full professor and Division Chair at Ohio State, became a Fellow of the American Association of Pharmaceutical Scientists, and later joined GTx as chief scientific officer.

James served as Dean of Pharmaceutical Sciences at the University of Michigan and was elected to the National Academy of Medicine. In 2020, Dalton became Executive Vice President and provost at the University of Alabama.

Patent №: 12128026 (October 29, 2024) – Selective androgen receptor degrader (SARD) ligands and methods of use thereof. This invention presents novel SARD compounds based on indole, indazole, benzimidazole, and related structures, along with pharmaceutical compositions for treating conditions such as prostate hyperproliferation, prostate cancer, androgenic alopecia, Kennedy’s disease, ALS, AAA, and uterine fibroids. The compounds act by reducing levels or inhibiting the activity of androgen receptors, including full-length receptors, splice variants, and pathogenic polyglutamine mutations.

Johan Furuskog

Johan Furuskog received his M.Sc. in engineering physics from Uppsala University, Sweden, in 2007.

After graduating, he joined Ericsson Research, Kista, Sweden, as a researcher.

Johan is currently involved in testbed projects targeting the design and deployment of future radio access technologies and works with concept development and evaluation of new components for the LTE standard.

Patent №: 12133238 (October 29, 2024) – Radio-network node, wireless device and methods performed therein. Embodiments describe a method where a radio-network node schedules resources for an uplink data transmission and a feedback transmission over the same channel. The node sends a control message to the wireless device, indicating the scheduled resources for both transmissions.

Zhuo Chen

Staff Engineer at InterDigital Communications.

Patent №: 12132785 (October 29, 2024) – Internet of things configurable event and action sequencing framework.

Configurable IoT event and action sequencing mechanisms link various IoT events to enable complex, efficient processing of data within IoT systems.

Yubo Lian

Mr. Lian Yubo is the Vice President of BYD Company Limited. He graduated from Nanjing University of Aeronautics and Astronautics in July 1986, with a bachelor’s degree majoring in aircraft manufacturing engineering.

In September 2000, he obtained a professional MBA degree from Nanjing University.

Mr. Lian joined the Company in February 2004 and is a Vice President of the Company and chief engineer of the automobile business.

He is also a director of Shenzhen DENZA New Energy Automotive Co., Ltd. and a director of BYD Charity Foundation since 2016.

Patent №: 12132182 (October 29, 2024) – Battery energy processing device and method, and vehicle. This disclosure describes a battery energy processing device and method for vehicles. The device includes a bridge arm converter linked to the battery’s electrodes, a motor winding, an energy storage device, and a controller. In a preset state, the controller manages charging and discharging to increase the battery’s temperature through internal resistance, enabling efficient battery heating.